EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer

Ioan Lucian Borza, Aurel Babes

Romanian Journal of Diabetes Nutrition and Metabolic Diseases · 2015

DOI: 10.1515/rjdnmd-2015-0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 2015. Verfasst von Ioan Lucian Borza und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: We evaluated fecal calprotectin values in patients with colorectal neoplasms undergoing surgery, comparatively in patients with and without diabetes mellitus. Material and Methods: We studied 40 patients operated for colorectal neoplasm, divided into two groups: one group of 20 patients with insulin-treated type 2 diabetes and another group of 20 patients without diabetes.

Results

Patients had a high percentage of preoperative calprotectin test positivity (90%, 36 patients). A total of 19 patients in group 1 and 17 patients in group 2 had a positive calprotectin test. Postoperatively at 3 months, fecal calprotectin values remained elevated in 7 patients from group 1 and 4 patients from group 2. At 6 months postoperatively, fecal calprotectin values remained elevated in 2 patients from group 1 and 1 patient from group 2.

Conclusions

Calprotectin values in faeces from patients with colorectal cancer were significantly increased, with a trend towards post-operatory normalization, slower in patients with diabetes. Fecal calprotectin value as a screening marker was almost equal compared to the hemoccult test, and better compared to that of the carcinoembryonic antigen.

Zitieren

APA

Borza, I. L., & Babes, A. (2015). Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. https://doi.org/10.1515/rjdnmd-2015-0002

Vancouver

Borza IL, Babes A. Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2015. doi:10.1515/rjdnmd-2015-0002

BibTeX
@article{Borza2015,
  author = {Borza, Ioan Lucian and Babes, Aurel},
  title = {Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer},
  journal = {Romanian Journal of Diabetes Nutrition and Metabolic Diseases},
  year = {2015},
  doi = {10.1515/rjdnmd-2015-0002}
}
Kostenlos starten →